Saturday 21 July 2018
 
»
Tag
 
»
MSD

Cervical cancer focus for MSD forum

MSD, a leading global biopharmaceutical company, recently hosted a round-table in Dubai,UAE to address the rising issue of the Human Papillomavirus (HPV) and the increasing risk of cervical cancer in the Mena region. The event, at

More…

Julphar-MSD partnership wins top ASAP award

Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa (MEA), has won the Association of Strategic Alliance Professionals (ASAP) award for 2018 along with its alliance partner, MSD.   MSD (known

More…

MSD unveils new resources for diabetes patients

MSD, known as Merck in the US and Canada, has launched new interactive and educational resources to help people with type 2 diabetes in the Middle East who choose to fast during Ramadan.   ‘The Facts About Fasting Durin

More…

Julphar in deal to produce, market MSD drugs

MSD, a global healthcare firm, and Julphar, a UAE-based pharmaceutical company, have signed a five-year agreement, which provides Julphar with exclusive rights to produce, market, distribute and sell certain MSD medicines in the region.

More…

Julphar in deal to produce, market MSD drugs

MSD, a global healthcare firm, and Julphar, a UAE-based pharmaceutical company, have signed a five-year agreement, which provides Julphar with exclusive rights to produce, market, distribute and sell certain MSD medicines in the region.

More…

MSD launches new fertility treatment

MSD, a global healthcare leader, has launched its new fertility treatment Elonva (Corifollitropin alfa) in Kuwait bringing new hope to thousands of couples across the country. Already a global issue, infertility affects an estimat

More…

MSD offers new treatment for hepatitis C

MSD, a global healthcare leader, today launched a new hepatitis C treatment that could provide a life line to thousands of UAE citizens. Up to 2 per cent of the UAE population suffers from hepatitis C, with many of them failing to be succe

More…

Type 2 diabetics 'face higher heart disease risk'

Cardiovascular diseases are the number one killer among Type 2 diabetes patients, according to a research by global healthcare major MSD. MSD presented its latest diabetes research and development insights during the Congress of the Intern

More…

MSD launches new CRM platform

MSD Egypt, a healthcare leader, has launched the MSD Connect platform, a Customer Relationship Management (CRM) system. The system helps to organise, automate and synchronise business processes and customer interactions, it said. M

More…

MSD drive tackles diabetes and fasting

MSD, a leading pharmaceutical company, launched of its diabetes awareness campaign, aiming to tackle the issue of Muslims with type 2 diabetes fasting during Ramadan despite serious health risks. Research shows that more than 50 million pe

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads